San Diego, CA, United States of America

Monika Gavireddi

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Mirati Therapeutics, Inc.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Monika Gavireddi. Retrieved from https://idiyas.com/inventor/monika-gavireddi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Monika Gavireddi: Innovator in Pharmaceutical Compositions

Introduction

Monika Gavireddi is a prominent inventor based in San Diego, California. She has made significant contributions to the field of pharmaceuticals, particularly in the development of solid pharmaceutical compositions. Her work is aimed at improving treatment options for cancer patients.

Latest Patents

Monika Gavireddi holds a patent for "Adagrasib solid pharmaceutical compositions." This patent involves pharmaceutical compositions in solid form that comprise adagrasib, which is suitable for oral dosage to treat subjects having cancer. The patent also includes methods of manufacturing these compositions and methods of treating cancer.

Career Highlights

Monika is currently employed at Mirati Therapeutics, Inc., where she continues to advance her research and development efforts. Her innovative work has the potential to significantly impact cancer treatment protocols.

Collaborations

Monika collaborates with talented professionals in her field, including Cletus Nunes and Mehrdad Kheiripour. These collaborations enhance the research and development process, leading to more effective pharmaceutical solutions.

Conclusion

Monika Gavireddi is a dedicated inventor whose work in pharmaceutical compositions is paving the way for new cancer treatments. Her contributions are vital to the ongoing fight against cancer, and her innovative spirit continues to inspire others in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…